Abstract:Background Vascular calcification (VC), associated with enhanced cardiovascular morbidity and mortality, is characterized by the osteogenic transdifferentiation of vascular smooth muscle cells. Inflammation promotes VC initiation and progression. Interleukin (IL)‐29, a newly discovered member of type III interferon, has recently been implicated in the pathogenesis of autoimmune diseases. Here we evaluated the role of IL‐29 in the VC process and underlying inflammatory mechanisms. Methods and Results The mRNA expression of IL‐29 was significantly increased and positively associated with an increase in BMP2 (bone morphogenetic protein 2) mRNA level in calcified carotid arteries from patients with coronary artery disease or chronic kidney disease. IL‐29 and BMP2 proteins are colocalized in human calcified arteries. IL‐29 binding to its specific receptor IL‐28Rα (IL‐28 receptor α) (IL‐29/IL‐28Rα) inhibited the proliferation of rat vascular smooth muscle cells without altering cell apoptosis or migration. IL‐29 promoted the calcification of rat vascular smooth muscle cells and their osteogenic transdifferentiation in vitro as well as the rat aortic ring calcification ex vivo, induced by the calcification medium or osteogenic medium. The procalcification effect of IL‐29 was reduced by pharmacological inhibition of IL‐29/IL‐28Rα binding as well as suppression of janus kinase 2/signal transducer and activator of transcription pathway activation, accompanied by decreased BMP2 expression in the cultured rat vascular smooth muscle cells. Conclusions These results suggest an important role of IL‐29 in VC development, at least partly, via activating the janus kinase 2/signal transducer and activator of transcription 3 signaling. Inhibition of IL‐29 or its specific receptor, IL‐28Rα, may provide a novel strategy to reduce VC in patients with vascular diseases. Nonstandard Abbreviations and Acronyms ARS alizarin red S BMP2 bone morphogenetic protein 2 VC vascular calcification VSMC vascular smooth muscle cell Clinical Perspective What Is New? Interleukin (IL)‐29 expression is increased in calcified carotid arteries from patients with coronary artery disease or chronic kidney disease, positively associated with BMP2 (bone morphogenetic protein 2) mRNA, and colocalizes with BMP2 protein. IL‐29, as a proinflammatory cytokine, binds to its specific receptor, IL‐28Rα (interleukin receptor α), on vascular smooth muscle cells, at least partly activating janus kinase 2/signal transducer and activator of transcription 3 signaling pathway to upregulate BMP2 expression in vascular smooth muscle cells, and promotes their osteogenic transformation and calcification. What Are the Clinical Implications? Our results indicate that inhibition of IL‐29/IL‐28Rα and/or janus kinase 2/signal transducer and activator of transcription 3 signaling using synthetic, small molecule inhibitors may be a useful strategy to reduce vascular calcification–related diseases. Vascular calcification (VC) is characterized by the deposition of calcium phosphate complexes in the arterial wall, and categorized by the intimal and medial calcification, depending on the sites of mineral deposition within the affected vessels. 1 Although it is regarded as a part of the normal aging process, VC has been implicated in the vascular pathogenesis associated with diabetes, 2 atherosclerosis, 3 and chronic kidney disease (CKD). 4 , 5 VC is considered as a hallmark of atherosclerosis and a key prognostic indicator of CKD that highly correlates with increased cardiovascular morbidity and mortality. 6 Although originally thought to be a passive, inevitable, and unregulated pathology process, VC is now appreciated to be an active and cell‐mediated process, 7 principally driven by vascular smooth muscle cells (VSMCs) 8 and tightly regulated by an array of inducers and inhibitors. 9 , 10 There is accumulating evidence suggesting that VSMC calcification plays a central role in the development and progression of VC. Importantly, phenotype sw -Abstract Truncated-

Inflammatory Cells Accelerated Carotid Artery Calcification via MMP9: Evidences From Single-Cell Analysis

LPS-induced senescence of macrophages aggravates calcification and senescence of vascular smooth muscle cells via IFITM3

Macrophages regulate vascular smooth muscle cell function during atherosclerosis progression through IL-1β/STAT3 signaling

Activation of CD137 Signaling Enhances Vascular Calcification Through C-Jun N-Terminal Kinase-Dependent Disruption of Autophagic Flux

Identification of MMP9 as a Novel Biomarker to Mitochondrial Metabolism Disorder and Oxidative Stress in Calcific Aortic Valve Stenosis

The miR-29b/Matrix Metalloproteinase 2 Axis Regulates Transdifferentiation and Calcification of Vascular Smooth Muscle Cells in a Calcified Environment

Transcriptome Analysis Revealed a Two-Step Transformation of Vascular Smooth Muscle Cells to Macrophage-Like Cells.

MicroRNA-32 Promotes Calcification in Vascular Smooth Muscle Cells: Implications As a Novel Marker for Coronary Artery Calcification.

Interleukin‐29 Accelerates Vascular Calcification via JAK2/STAT3/BMP2 Signaling

P1233M2 MACROPHAGES PROMOTE MOUSE AORTIC SMOOTH MUSCLE CELLS CALCIFICATION BY SGK1-TGFB1 AXIS

C5a-C5aR1 induces endoplasmic reticulum stress to accelerate vascular calcification via PERK-eIF2α-ATF4-CREB3L1 pathway

Autophagy reduces aortic calcification in diabetic mice by reducing matrix vesicle body-mediated IL-1β release

IL-17 Stimulates Migration of Carotid Artery Vascular Smooth Muscle Cells in an MMP-9 Dependent Manner via p38 MAPK and ERK1/2-Dependent NF-κB and AP-1 Activation

Matrix metallopeptidase 9 contributes to the beginning of plaque and is a potential biomarker for the early identification of atherosclerosis in asymptomatic patients with diabetes

Role of Macrophage-derived Osteoclasts in Vascular Calcification

Identification of miR136, miR155, and miR183 in vascular calcification in human peripheral arteries

Advanced Glycation End Products Induce Vascular Smooth Muscle Cell-Derived Foam Cell Formation and Transdifferentiate to a Macrophage-Like State.

The interaction of transient receptor potential melastatin 7 with macrophages promotes vascular adventitial remodeling in transverse aortic constriction rats

Matrix Metalloproteinases: Inflammatory Regulators of Cell Behaviors in Vascular Formation and Remodeling

Abstract Tu010: Matrix Metallopeptidase 9 Contributes to the Beginning of Plaque and is a Potential Biomarker for the Early Identification of Atherosclerosis in Asymptomatic Patients with Diabetes

Macrophage promote vascular calcification via the migrasomes/ integrin a5b1 pathway in ckd